Orphazyme
Pioneering therapies to address severe lysosomal storage disorders with roots in groundbreaking academic research from distinguished scientists.
General Information
Get notified when Orphazyme moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Orphazyme
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Orphazyme
Taxonomy: Orphazyme, lysosomal storage disorders, genetic conditions, therapy, academic research, scientific founders, Copenhagen, premier academic institutions, collaborations, innovative therapies, lysosomal storage diseases, discovery, Denmark, USA, Europe
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 07 Feb 2020 | |
| Venture Round | •••••• | 6 |
|
16 Nov 2017 |
| Venture Round | •••••• | 7 |
|
08 Mar 2017 |
| Series B | •••••• | 4 |
|
09 Jan 2015 |
| Grant | •••••• | 1 |
|
17 Sep 2014 |
Orphazyme Alternatives & Competitors
Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic...
Next generation enzyme replacement and gene therapies for rare diseases.
MyStudies.com helps students and parents with online academic assistance for writing and correcting...
FAQ About Orphazyme
Don't just browse. Track.
Signal Tracker monitors Orphazyme and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.